IL6 and age-related macular degeneration: As a result, variants of MIR146A may alter the interaction with mRNA targets (especially, CFH, IL-6, IRAK1, and HTRA2) and, consequently, contribute to exacerbate inflammatory signaling and immune response over activation typical of AMD.